References
- Stephens MAC, Wand G. Stress and the HPA axi: role of glucocorticoids in alcohol dependence. Alcohol research: current reviews; 2012.
- Vyas A, Mitra R, Rao BS, et al. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002;22(15):6810–6818.
- Miranda M, Morici JF, Zanoni MB, et al. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.
- Salehi B, Quispe C, Chamkhi I, et al. Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence. Front Pharmacol. 2021;11:592654.
- Kim HJ, Jang BK, Park J-H, et al. A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model. Eur J Med Chem. 2020;185:111777.
- Higgs J, Wasowski C, Marcos A, et al. Chalcone derivatives: synthesis, in vitro and in vivo evaluation of their anti-anxiety, anti-depression and analgesic effects. Heliyon. 2019;5(3):e01376.
- Liu H, Fan H, Gao X, et al. Design, synthesis and preliminary structure–activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives. J Enzyme Inhib Med Chem. 2016;31(4):580–589.
- N. Pesyan N, Noori S, Poorhassan S, et al. New spiro (thio) barbiturates based on cyclohexanone and bicyclo [3.1. 1] heptan-6-one by nonconcerted [1 + 5] cycloaddition reaction and their conformational structures. Bull Chem Soc Eth. 2014;28(3):423–440.
- Singh H, Sidhu S, Chopra K, et al. Hepatoprotective effect of trans-chalcone on experimentally induced hepatic injury in rats: inhibition of hepatic inflammation and fibrosis. Can J Physiol Pharmacol. 2016;94(8):879–887.
- Son H, Yang JH, Kim HJ, et al. A chronic immobilization stress protocol for inducing depression-like behavior in mice. JoVE. 2019;15(147):e59546.
- Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858.
- Radahmadi M, Alaei H, Sharifi MR, et al. Preventive and therapeutic effect of treadmill running on chronic stress-induced memory deficit in rats. J Bodyw Mov Ther. 2015;19(2):238–245.
- Breed MD, Moore J. Animal behavior (2nd edition). Academic Press; 2015.
- Wang D, Lu C-Y, Teng L-S, et al. Therapeutic effects of chinese herbal medicine against neuroendocrinological diseases especially related to hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axis. Pak J Pharm Sci. 2014:27(3):741–54.
- Larrieu T, Hilal L, Fourrier C, et al. Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl Psychiatry. 2014;4(9):e437-e.
- Mohammed H. Natural and synthetic flavonoid derivatives with potential antioxidant and anticancer activities. 2009.
- Wojcik M, Burzynska-Pedziwiatr I, Wozniak L. A review of natural and synthetic antioxidants important for health and longevity. Curr Med Chem. 2010;17(28):3262–3288.
- Obaid RJ, Mughal EU, Naeem N, et al. Natural and synthetic flavonoid derivatives as new potential tyrosinase inhibitors: a systematic review. RSC Adv. 2021;11(36):22159–22198.
- Zhang Y, He Y, Deng N, et al. Protective effect of resveratrol against corticosterone-induced neurotoxicity in PC12 cells. Transl Neurosci. 2019;10(1):235–240.
- Dieterich A, Srivastava P, Sharif A, et al. Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice. Transl Psychiatry. 2019;9(1):1–13.
- Zhang Q, Wang X, Bai X, et al. Resveratrol reversed chronic restraint stress-induced impaired cognitive function in rats. Mol Med Rep. 2017;16(2):2095–2100.
- Domes G, Frings C. Stress and cognition in humans. Exp Psychol. 2020;67(2):73–76.
- Conrad CD. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci. 2008;19(6):395–412.
- Liang K-C. Involvement of the amygdala and its connected structures in formation and expression of inhibitory avoidance memory: issues and implications. Chin J Physiol. 2009;52(4):196–214.
- Fanselow MS, Dong H-W. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65(1):7–19.
- Fanselow MS, LeDoux JE. Why we think plasticity underlying pavlovian fear conditioning occurs in the basolateral amygdala. Neuron. 1999;23(2):229–232.
- Arias N, Méndez M, Arias JL. The importance of the context in the hippocampus and brain related areas throughout the performance of a fear conditioning task. Hippocampus. 2015;25(11):1242–1249.
- Yao R, Nishii K, Aizu N, et al. Maintenance of the Amygdala-Hippocampal circuit function with safe and feasible shaking exercise therapy in SAMP-10 mice. Dement Geriatr Cogn Disord Extra. 2021;11(2):114–117.
- Rolls ET, Critchley HD, Treves A. Representation of olfactory information in the primate orbitofrontal cortex. J Neurophysiol. 1996;75(5):1982–1996.
- Daumas S, Halley H, Francés B, et al. Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn Mem. 2005;12(4):375–382.
- Wang Q-M, Wang G-L, Ma Z-G. Protective effects of myricetin on chronic stress-induced cognitive deficits. Neuroreport. 2016;27(9):652–658.
- Inoue R, Abdou K, Hayashi-Tanaka A, et al. Glucocorticoid receptor-mediated amygdalar metaplasticity underlies adaptive modulation of fear memory by stress. Elife. 2018;7:e34135.
- Lucassen PJ, Oomen CA, Naninck EF, et al. Regulation of adult neurogenesis and plasticity by (early) stress, glucocorticoids, and inflammation. Cold Spring Harb Perspect Biol. 2015;7(9):a021303.
- Lipsky RH, Marini AM. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci. 2007;1122(1):130–143.
- Leal G, Bramham C, Duarte C. BDNF and hippocampal synaptic plasticity. Vitam Horm. 2017;104:153–195.
- Murakami S, Imbe H, Morikawa Y, et al. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res. 2005;53(2):129–139.
- Soavi C, Marušič U, Sanz JM, et al. Age-related differences in plasma BDNF levels after prolonged bed rest. J Appl Physiol (1985). 2016;120(10):1118–1123.
- Shi S-S, Shao S-h, Yuan B-P, et al. Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med J. 2010;51(5):661–671.
- Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(1 Suppl):230S–242S.
- Wu D. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx. 2005;2(1):120–128.
- Ochs G, Penn RD, York M, et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(3):201–206.
- Kalra S, Genge A, Arnold DL. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(1):22–26.
- Pardridge WM, Kang Y-S, Buciak JL. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood − brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res. 1994;11(5):738–746.
- Kishino A, Katayama N, Ishige Y, et al. Analysis of effects and pharmacokinetics of subcutaneously administered BDNF. Neuroreport. 2001;12(5):1067–1072.